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1. Introduction 
Modern drug testing and design includes experimental in vivo and in vitro measurements, 
combined with in silico computations that enable prediction of the drug candidate’s ADMET 
(adsorption, distribution, metabolism, elimination and toxicity) properties in the early stages 
of drug discovery. Recent estimates place the discovery and development cost of a small 
drug molecule close to US $1.3 billion, from the time of inception to the time when the drug 
finally reaches the market place. Only 20 % of conceived drug candidates proceed to clinical 
trial stage testing, and of the compounds that enter clinical development less than 10 % 
receive government approval. Reasons for the low success rate include unsatisfactory 
efficacy, poor solubility, poor bioavailability, unfavorable pharmacokinetic properties, 
toxicity concerns and drug-drug interactions, degradation and poor shelf-life stability. 
Unfavorable pharmacokinetic and ADME properties, toxicity and adverse side effects 
account for up to two-thirds of drug failures. Traditional ADME analyses relied heavily on 
whole animal assays and the more labor intensive biochemical studies. High throughput 
screening methods, fast ADMET profiling assays, and computational approaches have 
allowed the pharmaceutical industry to identify quickly the less promising drug candidates 
in the very early development stage so that time and valuable resources are not spent 
pursuing compounds that have little probability of reaching the general population. 
Of the fore-mentioned properties, the drug’s aqueous solubility will likely be one of the first 
properties measured. Aqueous solubility is a major indicator of the drug’s solubility in 
physiological gastrointestinal fluids and is a major indicator of the drug’s oral 
bioavailability. Approximately 40 % of the proposed new pharmaceutical candidates are 
rejected in the very early stages of drug discovery because of their poor aqueous solubility 
resulting in bioavailability problems (Lukyanov and Torchilin, 2004; Keck et al., 2008). The 
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number of failures due to poor solubility is likely to increase in future years because the new 
drug candidates generally have higher molecular weights and more complicated molecular 
structures than their predecessors. Moreover, drug molecules that are insoluble in water are 
difficult to study with existing in vitro biological assays, often give unreliable biological test 
results, and may precipitate from solution during storage or upon dilution. The importance 
of aqueous solubility in drug design is further evidenced by the fact that the editors of one 
prominent computational journal (Llinàs et al., 2008) challenged readers to develop in silico 
methods to predict the intrinsic solubilities of 32 crystalline drug like molecules in water 
from an experimental data set of accurately measured solubilities of 100 compounds. Only a 
few of the more successful approaches were actually published (Wang, et al. 2009; Hewitt et 
al., 2009). Similar challenges have been published regarding the prediction and 
measurement of the hydration free energies of functionally diverse neutral drug-like 
molecules (Nicholls et al., 2008; Guthrie, 2009). Aqueous solubility is the reference media to 
predict the absorption and bioavailability of orally administered drugs. More than 85 % of 
the drugs sold in the US and in Europe are administered orally.  
Amidon and coworkers (1995) proposed a biopharmaceutical classification scheme (BCS) to 
categories drugs and drug candidates into four groups based on their combined solubility 
and permeability properties. The classification scheme is depicted in Figure 1a. Drug 
candidates in Class I exhibit high solubility and high permeability, which is preferred from 
both a bioavailability and drug delivery standpoint.  A drug candidate is considered highly 
soluble when the highest dose strength is soluble in 250 ml water over a pH range 1 to 7.5. A 
drug candidate possesses high permeability when the extent of absorption in humans is 
determined to be 90% of an administered dose, based on the mass balance or in comparison 
to an intravenous dose. Drug candidates in Class II have low solubility and high 
permeability, hence, the dissolution rate becomes the governing parameter for 
bioavailability. These drugs exhibit variable bioavailability and need enhancement in the 
dissolution rate for improvement in bioavailability. Drug candidates in Class III have high 
solubility and low permeability. Permeation through the intestinal membrane represents the 
rate-determining step for Class III drug candidates, with the bioavailability being 
independent of drug release from the dosage form. Class IV drug candidates possess both 
low solubility and low permeability. Drugs in this category are generally not suitable for 
oral drug delivery unless one employs a special drug delivery technology (such as a nano-
suspension). Wu and Benet (2005) examined the biopharmaceutical classification scheme as 
a predictive method for assessing drug disposition. The authors found that drugs in Classes 
I and II of BCS were metabolized and eliminated. Drugs in the latter two classes were 
eliminated unchanged from the body by renal and/or biliary elimination. On the basis of 
these findings the authors suggested the Biopharmaceutics Drug Disposition Classification 
System (BDDCS) where the extent of metabolism has replaced permeability as a 
classification criterion (see Figure 2b). Aqueous solubility is an important consideration in 
both drug classification systems. Adverse drug solubility can sometimes be overcome by 
structural modifications (e.g., prodrugs) or by adding an organic cosolvent, surfactant, 
hydrophilic macromolecular and/or an inclusion host compound (such as a modified 
cyclodextrin) to the drug formulation or application vehicle. Knowledge of the drug’s 
solubility in different organic solvents aids in the selection of an appropriate organic 
cosolvent and provides valuable information regarding drug’s molecular interactions with 
other organic molecules.  
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Fig. 1. Properties used in the Biopharmaceutical Classification Scheme (a) and 
Biopharmaceutics Drug Disposition Classification System (b) 
Lipophilicity is another of the physical properties that is measured in the early stages of 
drug testing to predict the transport of molecules from the gastrointestinal track into the 
epithelial cells that line the inner and outer surfaces of the body. Most common drugs cross 
cellular barriers by transcellular pathways (across epithelial cells) that require the drug to 
enter the outer portion of the lipid bilayer of the cell membrane. The drug then diffuses to 
the inner lipid layer and travels across the cell before crossing the cell membrane once again 
to exit. Lipophilicity was introduced to describe a compound’s affinity to be in lipid-like 
environment. Several solvent systems have been suggested as a surrogate to represent the 
lipid membrane against water. For convenience and economical reasons, the partition 
coefficient of the drug candidate between 1-octanol and a series of aqueous buffers has 
become the standard measure of lipophilicity. The intrinsic lipophilicity (logarithm of the 
water-to-octanol partition coefficient, log Po/w) describes the equilibrium distribution of 
molecular drug candidate (unionized form of the molecule) between water and the aqueous 
buffer, and is independent of pH. The effective lipophilicity (logarithm of the water-to-octanol 
distribution coefficient) reflects the concentration ratio of the neutral drug molecule plus all 
ionized forms that may be present in the aqueous buffered solution at the given pH. The 
effective lipophilicity is often quoted at the physiological pH of 7.4. The intrinsic and 
effective lipophilicities are equivalent if the drug candidate contains no ionizable or 
protonatable functional groups. Experimental techniques employed to measure water-to-
octanol partition coefficients include the traditional shake-flask method, as well as several 
methods based on reversed-phase liquid chromatography (hplc), counter-current 
chromatography and centrifugal partition chromatography (Sangster, 1989; Berthod et al., 
1992; Menges et al., 1990; Berthod et al., 1988; McDuffie, 1981; Veith et al., 1979). Ribeiro and 
coworkers (2010) recently discussed the advantages and limitations associated with using 
the water-to-octanol partitioning system as a surrogate for biological membranes. The 
authors noted that there is a considerable difference between the homogeneous macroscopic 
1-octanol solvent system and the highly-ordered microscopic structure of a lipid layer. 
Chromatographic retention data determined using an immobilized artificial membrane 
(IAM) stationary phase was suggested as a more appropriate method for measuring the 
lipophilicity of drug candidates and for quantifying drug-membrane interactions. 
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Solubility and water-to-organic solvent partition coefficients are fairly easy to measure as 
the equilibrated solutions contain only the dissolved drug candidate and the solubilizing 
solvent media. Blood-to-tissue partition coefficients, plasma-to-milk partition coefficient, 
percentage of human intestinal absorption and the steady-state volume of distribution are 
much harder to measure. The analytical methodology employed to measure these latter 
properties must be able to distinguish and quantify the drug from all of the many other 
molecules present in the biological sample. It is not easy, even with today’s modern 
instrumentation, to design chemical analysis methods that are specific to a given molecule. 
Moreover, measurements involving human and/or animal tissues are expensive and are 
subject to larger experimental uncertainties. Replicate studies involving the same animal 
species have shown that the measured values can depend on gender, age and eating habits. 
This chapter will discuss the prediction of the blood-to-tissue partition coefficients, plasma-
to-milk partition coefficients, human intestinal absorption based on the Abraham solvation 
parameter model and solute descriptors calculated from measured solubilities and partition 
coefficients. 
2. Abraham solvation parameter model  
The Abraham general solvation model is one of the more useful approaches for the analysis 
and prediction of the adsorption, distribution and toxicological properties of potential drug 
candidates. The method relies on two linear free energy relationships (lfers), one for transfer 
processes occurring within condensed phases (Abraham, 1993a,b; Abraham et al., 2004): 
 SP  c  e ·  s ·  a ·  b ·  v ·     E S A B V  (1) 
and one for processes involving gas-to-condensed phase transfer 
 SP  c  e ·  s ·  a ·  b ·  l ·     E S A B L  (2) 
The dependent variable, SP, is some property of a series of solutes in a fixed phase, which in 
the present study will include the logarithm of drug’s water-to-organic solvent and blood-
to-tissue partition coefficients, the logarithm of the drug’s molar solubility in an organic 
solvent divided by its aqueous molar solubility, the logarithm of the drug’s plasma-to-milk 
partition coefficient, percent human intestinal absorption and the logarithm of the kinetic 
constant for human intestinal absorption, and the logarithm of the human skin permeability 
coefficient. The independent variables, or descriptors, are solute properties as follows: E and 
S refer to the excess molar refraction and dipolarity/polarizability descriptors of the solute, 
respectively, A and B are measures of the solute hydrogen-bond acidity and basicity, V is 
the McGowan volume of the solute and L is the logarithm of the solute gas phase 
dimensionless Ostwald partition coefficient into hexadecane at 298 K. The first four 
descriptors can be regarded as measures of the tendency of the given solute to undergo 
various solute-solvent interactions. The latter two descriptors, V and L, are both measures of 
solute size, and so will be measures of the solvent cavity term that will accommodate the 
dissolved solute. General dispersion interactions are also related to solute size, hence, both 
V and L will also describe the general solute-solvent interactions. Solute descriptors are 
available for more than 4,000 organic, organometallic and inorganic solutes. No single article 
lists all of the numerical values; however, a large compilation is available in one published 
review article (Abraham et al., 1993a), and in the supporting material that has accompanied 
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several of our published papers (Abraham et al., 2006a; Abraham et al., 2009a; Mintz et al., 
2007). Solute descriptors can be obtained by regression analysis using various types of 
experimental data, including water-to-solvent partitions, gas-to-solvent partitions, solubility 
data and chromatographic retention data as discussed below and elsewhere (Abraham et al., 
2010; Zissimos et al., 2002a,b). For a number of partitions into solvents that contain large 
amounts of water at saturation, an alternative hydrogen bond basicity parameter, Bo, is used 
for specific classes of solute: alkylpyridines, alkylanilines, and sulfoxides.  
Equations 1 and 2 contain the following three quantities: (a) measured solute properties; (b) 
calculated solute descriptors; and (c) calculated equation coefficients. Knowledge of any two 
quantities permits calculation of the third quantity through the solving of simultaneous 
equations and regression analysis. Solute descriptors are calculated from measured partition 
coefficient (Psolute,system), chromatographic retention factor (k’) and molar solubility 
(Csolute,solvent) data for the solutes dissolved in partitioning systems and in organic solvents 
having known equation coefficients. Generally partition coefficient, chromatographic 
retention factor and molar solubility measurements are fairly accurate, and it is good 
practice to base the solute descriptor computations on observed values having minimal 
experimental uncertainty. The computation is depicted graphically in Figure 1 by the 
unidirectional arrows that indicate the direction of the calculation using the known equation 
coefficients that connect the measured and solute descriptors. Measured Psolute,system and 
Csolute,solvent values yield solute descriptors. The unidirectional red arrows originating from 
the center solute descriptor circle represent the equation coefficients that have been reported 
for blood-to-brain partition coefficient, blood-to-tissue partition coefficients, percentage of 
human intenstinal absorption, Draize eye scores, and aquatic toxicity Abraham model linear 
free energy relationships. Plasma-to-milk partition ratio predictions are achieved (Abraham 
et al., 2009b) through an artificial neural network with five inputs, 14 nodes in the hidden 
layer and one node in the output layer. Linear analysis of the plasma-to-milk partition ratios 
for 179 drugs and hydrophobic environmental pollutants revealed that drug molecules 
preferentially partition into the aqueous and protein phases of milk. Hydrophobic 
environmental pollutants, on the other hand, partition into the fat phase. Prediction of the 
fore-mentioned ADMET and biological properties does require a prior knowledge of the 
Abraham solute descriptors for the drug candidate of interest. There are also commercial 
software packages (ADME Boxes, 2010) and several published estimation schemes (Mutelet 
and Rogalski, 2001; Arey et al., 2005; Platts et al., 1999; Abraham and McGowan, 1987) for 
calculating the numerical values of solute descriptors from molecular structural information 
if one is unable to find the necessary partition, chromatographic and/or solubility data. For 
any fully characterized system/process (those with calculated values for the equation 
coefficients) further values of SP can be estimated for solutes with known values for the 
solute descriptors.  
The usefulness of Eqns. 1 and 2 in the characterization of solvent phases is that the 
coefficients e, s, a, b, l and v are not just curve-fitting constants. The coefficients reflect 
particular solute-solvent interactions that correspond to chemical properties of the solvent 
phase. The excess molar refraction, E, is defined from the solute refractive index, and hence 
the e coefficient gives a measure of general solute-solvent dispersion interactions.  The V 
and L descriptors were set up as measures of the endoergic effect of disrupting solvent-
solvent bonds. However, solute volume is always well correlated with polarizability and so 
the v and l coefficients will include not only an endoergic cavity effect but also exoergic solute-
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solvent effects that arise through solute polarizability. The S descriptor is a measure of 
dipolarity and polarizability and hence the s coefficient will reflect the ability of a solvent to 
undergo dipole-dipole and dipole-induced dipole interactions with the solute. The A 
descriptor is a measure of solute hydrogen bond acidity, and hence the a coefficient will reflect 
the complementary solvent hydrogen bond basicity. Similarly the b coefficient will be a 
measure of solvent hydrogen bond acidity. All this is straightforward for gas-to-solvent 
partitions because there are no interactions to consider in the gas phase. For partition between 
solvents, the coefficients in Eqn. 1 then refer to differences between the properties of the two 
phases. 
 
 
Fig. 2. Outline illustrating the calculation of Abraham model solute descriptors from 
experimental partition coefficient and solubility data, and then using the calculated values 
to estimate biological activities and partitioning, such as blood-to-tissue partition 
coefficients, Draize eye scores, aquatic toxicities and air-to-blood partition coefficients. 
The Abraham model equation coefficients encode chemical information, and several 
methods have been suggested to assess the chemical similarity between different 
partitioning processes/systems. Abraham and Martins (2004) calculated the five-
dimensional distance between the coefficients as points in five-dimensional space by 
straightforward geometry 
 2 2 2 2 2iDistance  (e ) ( ) ( ) ( ) ( )j i j i j i j i je s s a a b b v v           (3) 
where the subscripts “i” and “j” denote the two partitioning processes being compared. For 
comparison purposes, the authors suggested that for a good chemical model the calculated 
distance should be less than about 0.5 – 0.8.  The water-to-isobutanol and water-to-octanol 
partitioning systems were the two chemical systems that the authors found closest to human 
skin permeability, with calculated distances of 1.2 and 1.9, respectively. The chemical 
interactions that govern skin permeability were quite different from the chemical 
interactions governing solute partitioning between water and isobutanol, and between 
water and 1-octanol. Ishiharma and Asakawa (1999) suggested a different comparison 
method based on calculating the cosine of the angle (cos θij) between the coefficients 
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 (4) 
which are now regarded as lines in five-dimensional space. The angle between the two lines, 
θij, yields information regarding how the two compared processes are in terms of their 
chemical similarity. As θij approaches zero (or alternatively as cos θij approaches unity) the 
two lines coincide, and the correlation between the two partitioning processes/systems 
approaches unity. Analysis of the Abraham model coefficients for the solubility of gases and 
vapors in biological phases (blood, brain, fat, heart, kidney, liver, lung and muscle) and 
organic solvents (alcohols, amides, olive oil, chloroform, diethyl ether, butanone), and 
equation coefficients for biological activity (nasal pungency thresholds, eye irritation 
thresholds, odor detection and anesthesia) using Eqns. 3 and 4 (along with Principal 
Component Analysis) found N-methylformamide to be an excellent model for both eye 
irritation thresholds in humans and nasal pungency thresholds in humans (Abraham et al., 
2009a). The receptor site controlling both biological responses must be protein-like in 
character. The study further showed that no organic solvent is a suitable model (or 
surrogate) for blood, brain, heart, kidney, liver, lung and muscle. Two relatively nonpolar 
solvents (olive oil and chloroform) were found to be suitable models for fat, which is not too 
surprising given that fat is about 80 % lipid. 
3. Experimental methods for measuring thermodynamic and kinetic 
solubilities 
Recent advances in automated chemical synthesis and combinatorial chemistry have 
generated large numbers of new chemical compounds that need to be screened for possible 
biological activity and desired ADMET properties. The conventional experimental methods 
that were once used in the pharmaceutical industry to measure solubility and water-to-
organic solvent partition coefficients are inadequate to handle large numbers of new 
compound because of low throughput capacity and the amount of compound required for 
the experimental determination. Large quantities of highly purified compounds are not 
usually available in the initial stages of drug discovery and drug testing. To meet the 
demands imposed by the increased compound numbers, the pharmaceutical industry has 
developed miniaturized and automated sample preparation platforms, combined with rapid 
chemical analysis methods based on nephelometric, uv/visible absorption and/or 
chromatographic measurements. The experimental protocol used depends on whether one 
needs to measure the kinetic or thermodynamic solubility.  
High throughput kinetic aqueous solubility assays are based on the detection of 
precipitation of compounds in aqueous or aqueous buffered solutions. Typically, small 
known aliquots of the stock solution are added incrementally to the aqueous (or aqueous 
buffered solution) at predetermined time intervals until the solubility limit is reached. The 
resulting precipitation can be detected optically by nephlometric or laser monitoring 
methods, and the kinetic solubility is defined as the solute concentration immediately 
preceding the point at which precipitation was first detected. Kinetic solubility thus 
represents the maximum solubility of the fastest precipitation species of the given 
compound into the desired solubilizing solvent media. Numerous modifications of kinetic 
assays have been suggested in recent years. The suggested modifications differ in the 
dilution and detection method. For example, Lipinski et al. (2001) added small aliquots of a 
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stock solution of the drug (dissolved in dimethyl sulfoxide, DMSO) to the aqueous solvent 
media every minute until precipitation occurred. The DMSO in solution did increase with 
each added aliquot and may result in a higher measured aqueous solubility. Dimethyl 
sulfoxide is known to increase the solubility by helping to solvate the more lipophilic drug 
compounds. Solubility enhancement by dimethyl sulfoxide can be reduced if the samples 
are first serially diluted in dimethyl sulfoxide before the aliquots are added to the aqueous 
solvent system. Special 96-well plates have been designed to facilitate high throughput 
solubility measurements. The method depicted in Figure 3 allows one to quickly measure 
the aqueous solubility and aqueous-buffered solubility of 12 different drug candidates. The 
eight DMSO-diluted concentrations (1 mM to 100 mM) of each drug candidate are placed in 
the specified well of the drug’s respective column. In the 12 x 9 cell matrix, the drug is 
identified by column number and the concentration is identified by row number. A 
predetermined aliquot volume from each of the DMSO diluted sample wells is transferred 
to the corresponding cell in the aqueous plate and aqueous-buffered plate. The volume of 
DMSO-diluted sample is the same for each transferred aliquot. Each cell in the aqueous 
plate and aqueous-buffered plate contains an identical volume of solvent. The cell contents 
are examined for precipitation immediately after the passage of the defined time interview, 
or alternatively, one can remove the solid and determine the concentration of dissolved 
drug by standard spectroscopic and/or chromatographic methods. 
 
 
Fig. 3. Outline of a high throughput method for measuring drug solubility in water and in 
an aqueous-buffered solution using a 96-well plate.   
Kinetic methods often overestimate the thermodynamic drug solubility because of the 
increased solubilization effect caused by the presence of dimethyl sulfoxide in the aqueous 
solvent and by the fact that one has not allowed sufficient time for equilibrium to be 
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achieved. Thermodynamic solubility is defined as the concentration in solution of a 
compound in equilibrium with an excess of solid material being present in solution at the 
conclusion of the dissolution process. Thermodynamic solubility is considered the “true” 
solubility of a compound. Experimental methods for determining thermodynamic solubility 
may be grouped into categories, one that extends the experimental protocols of exiting 
kinetic solubility determinations to longer “equilibration times” and the other that conducts 
solubility studies on solid compounds obtained from dried stock solutions to remove the 
enhancement effects caused by having the added dimethyl sulfoxide present in the final 
equilibrated solution.  The rationale behind the longer equilibration times is that sufficient 
time will now be afforded for the first-precipitated crystalline phase to convert to the more 
thermodynamically stable crystalline phase. Sugano and coworkers (2006) reported a 
significant decrease in solubility with equilibration time for more than half of the 26 model 
compounds studied. 
The preceding discussion focused on aqueous kinetic and thermodynamic solubility 
measurements. There is no reason that the basic high throughput experimental 
methodologies cannot be applied to organic solvents and to aqueous-organic solvent 
mixtures. Measured drug solubility in organic solvents, in combination with the Abraham 
general solvation model, provides valuable information in regarding the molecule’s 
hydrogen-bonding character and dipolarity.  Solubility ratios are substituted into Eqns. 1 
and 2 to give the following mathematical correlations: 
  A,organic A,waterlog C /C   c  e ·  s ·  a ·  b ·  v ·     E S A B V  (5) 
  A,organic A,gaslog C /C   c  e ·  s ·  a ·  b ·  l ·     E S A B L  (6) 
where CA,organic and CA,water denote the molar solubility of the solute (component A) in the 
anhydrous “dry” organic solvent and in water, respectively, and CA,gas is the molar gas 
phase concentration of the solute above the crystalline phase at the system temperature. This 
later quantity is calculable as CA,gas = PAo V/RT, from the solute’s vapor pressure above the 
crystalline phase, PAo.   
The solubility ratio in Eqn. 5 represents a hypothetical partitioning process for transferring 
the solute from water to the anhydrous organic solvent as depicted in Figure 4. Also 
depicted in Figure 4 are the gas-to-water and gas-to-organic solvent partitioning processes, 
along with their respective concentration ratios. The hypothetical water-to-organic solvent 
partitioning process should not be confused with the direct practical organic solvent/water 
partitioning system that corresponds to the equilibrium solute partitioning between a water-
saturated organic phase and an aqueous phase saturated with the organic solvent. For 
solvents that are partially miscible with water, such as 1-butanol and ethyl acetate, partition 
coefficients calculated as the ratio of the molar solute solubilities in the organic solvent and 
water are not the same as those obtained from direct partition between water (saturated 
with the organic solvent) and organic solvent (saturated with water). Solubility ratios and 
practical partition coefficients, however, are nearly identical for solvents like linear alkanes, 
cycloalkanes, chloroform, carbon tetrachloride and dichloromethane, which are almost 
“completely” immiscible with water. Tables 1 and 2 give the equation coefficients for the 
Abraham model solubility ratio correlations (Eqns. 5 and 6) for the different organic solvents 
that have been reported to date. 
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Fig. 4. Solubility ratios describing the various solute transfer processes. 
 
Dry Solvent c e s a b v 
Olely alcohol  -0.096 0.148 -0.841 -0.438 -4.040 4.125 
Dichloromethane  0.319 0.102 -0.187 -3.058 -4.090 4.324 
Trichloromethane  0.191 0.105 -0.403 -3.112 -3.514 4.395 
Tetrachloromethane  0.199 0.523 -1.159 -3.560 -4.594 4.618 
1,2-Dichloroethane  0.183 0.294 -0.134 -2.801 -4.291 4.180 
1-Chlorobutane  0.222 0.273 -0.569 -2.918 -4.883 4.456 
Butane  0.297 -0.005 -1.584 -3.188 -4.567 4.562 
Pentane  0.369 0.386 -1.568 -3.535 -5.215 4.514 
Hexane  0.361 0.579 -1.723 -3.599 -4.764 4.344 
Heptane  0.325 0.670 -2.061 -3.317 -4.733 4.543 
Octane  0.223 0.642 -1.647 -3.480 -5.067 4.526 
Nonane  0.240 0.619 -1.713 -3.532 -4.921 4.482 
Decane  0.160 0.585 -1.734 -3.435 -5.078 4.582 
Undecane  0.058 0.603 -1.661 -3.421 -5.120 4.619 
Dodecane  0.114 0.668 -1.664 -3.545 -5.006 4.459 
Hexadecane  0.087 0.667 -1.617 -3.587 -4.869 4.433 
Cyclohexane  0.159 0.784 -1.678 -3.740 -4.929 4.577 
Methylcyclohexane  0.246 0.782 -1.982 -3.517 -4.293 4.528 
Isooctane  0.318 0.555 -1.737 -3.677 -4.864 4.417 
Benzene  0.142 0.464 -0.588 -3.099 -4.625 4.491 
Toluene  0.143 0.527 -0.720 -3.010 -4.824 4.545 
Fluorobenzene  0.139 0.152 -0.374 -3.030 -4.601 4.540 
Chlorobenzene  0.065 0.381 -0.521 -3.183 -4.700 4.614 
Bromobenzene  -0.017 0.436 -0.424 -3.174 -4.558 4.445 
Iodobenzene  -0.192 0.298 -0.308 -3.213 -4.653 4.588 
Nitrobenzene  -0.152 0.525 0.081 -2.332 -4.494 4.187 
Benzonitrile 0.155 0.337 -0.036 -1.544 -4.614 3.990 
Olive oil  -0.035 0.574 -0.798 -1.422 -4.984 4.210 
Carbon disulfide  0.047 0.686 -0.943 -3.603 -5.818 4.921 
Isopropyl myristate -0.605 0.930 -1.153 -1.682 -4.093 4.249 
Triolein  0.385 0.983 -2.083 -2.007 -3.452 4.072 
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Dry Solvent c e s a b v 
Methanol  0.276 0.334 -0.714 0.243 -3.320 3.549 
Ethanol  0.222 0.471 -1.035 0.326 -3.596 3.857 
Propan-1-ol  0.139 0.405 -1.029 0.247 -3.767 3.986 
Butan-1-ol  0.165 0.401 -1.011 0.056 -3.958 4.044 
Pentan-1-ol 0.150 0.536 -1.229 0.141 -3.864 4.077 
Hexan-1-ol 0.115 0.492 -1.164 0.054 -3.978 4.131 
Heptan-1-ol 0.035 0.398 -1.063 0.002 -4.343 4.317 
Octan-1-ol -0.034 0.489 -1.044 -0.024 -4.235 4.218 
Decan-1-ol -0.058 0.616 -1.319 0.026 -4.153 4.279 
Propan-2-ol 0.099 0.343 -1.049 0.406 -3.827 4.033 
Isobutanol 0.127 0.253 -0.976 0.158 -3.882 4.114 
sec-Butanol 0.188 0.354 -1.127 0.016 -3.568 3.968 
tert-Butanol 0.211 0.171 -0.947 0.331 -4.085 4.109 
3-Methyl-1-butanol 0.073 0.360 -1.273 0.090 -3.770 4.273 
Pentan-2-ol 0.115 0.455 -1.331 0.206 -3.745 4.201 
Ethylene glycol -0.270 0.578 -0.511 0.715 -2.619 2.729 
2,2,2 -Trifluoroethanol 0.395 -0.094 -0.594 -1.280 -1.274 3.088 
Diethyl ether  0.350 0.358 -0.820 -0.588 -4.956 4.350 
Tetrahydrofuran 0.207 0.372 -0.392 -0.236 -4.934 4.447 
1,4-Dioxane 0.098 0.350 -0.083 -0.556 -4.826 4.172 
Dibutyl ether 0.176 0.394 -0.985 -1.414 -5.357 4.524 
Methyl tert-butyl ether 0.341 0.307 -0.817 -0.618 -5.097 4.425 
Methyl acetate 0.351 0.223 -0.150 -1.035 -4.527 3.972 
Ethyl acetate  0.328 0.369 -0.446 -0.700 -4.904 4.150 
Butyl acetate 0.248 0.356 -0.501 -0.867 -4.973 4.281 
Propanone 0.313 0.312 -0.121 -0.608 -4.753 3.942 
Butanone 0.246 0.256 -0.080 -0.767 -4.855 4.148 
Cyclohexanone 0.038 0.225 0.058 -0.976 -4.842 4.315 
Dimethylformamide -0.305 -0.058 0.343 0.358 -4.865 4.486 
Dimethylacetamide -0.271 0.084 0.209 0.915 -5.003 4.557 
Diethylacetamide 0.213 0.034 0.089 1.342 -5.084 4.088 
Dibutylformamide 0.332 0.302 -0.436 0.358 -4.902 3.952 
N-Methylpyrolidinone 0.147 0.532 0.225 0.840 -4.794 3.674 
N-Methyl-2-piperidone 0.056 0.332 0.257 1.556 -5.035 3.983 
N-Formylmorpholine -0.032 0.696 -0.062 0.014 -4.092 3.405 
N-Methylformamide 0.114 0.407 -0.287 0.542 -4.085 3.471 
N-Ethylformamide 0.220 0.034 -0.166 0.935 -4.589 3.730 
N-Methylacetamide 0.090 0.205 -0.172 1.305 -4.589 3.833 
N-Ethylacetamide 0.284 0.128 -0.442 1.180 -4.728 3.856 
Formamide -0.171 0.070 0.308 0.589 -3.152 2.432 
Acetonitrile 0.413 0.077 0.326 -1.566 4.391 3.364 
Nitromethane 0.023 -0.091 0.793 -1.463 -4.364 3.460 
Dimethylsulfoxide -0.194 0.327 0.791 -1.260 -4.540 3.361 
Tributylphosphate 0.327 0.570 -0.837 -1.069 -4.333 3.919 
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Dry Solvent c e s a b v 
Propylene carbonate 0.004 0.168 0.504 -1.283 -4.407 3.421 
Gas-water -0.994 0.577 2.549 3.813 4.841 -0.869 
Table 1. Coefficients in Eqn. 5 for Correlating Solute Solubility in Dry Organic Solvents at 
298 K 
 
Dry Solvent c e s a b l 
Olely alcohol  -0.268 -0.392 0.800 3.117 0.978 0.918 
Dichloromethane  0.192 -0.572 1.492 0.460 0.847 0.965 
Trichloromethane  0.157 -0.560 1.259 0.374 1.333 0.976 
Tetrachloromethane  0.217 -0.435 0.554 0.000 0.000 1.069 
1,2-Dichloroethane  0.017 -0.337 1.600 0.774 0.637 0.921 
1-Chlorobutane  0.130 -0.581 1.114 0.724 0.000 1.016 
Butane  0.291 -0.360 0.091 0.000 0.000 0.959 
Pentane  0.335 -0.276 0.000 0.000 0.000 0.968 
Hexane  0.292 -0.169 0.000 0.000 0.000 0.979 
Heptane  0.275 -0.162 0.000 0.000 0.000 0.983 
Octane  0.215 -0.049 0.000 0.000 0.000 0.967 
Nonane  0.200 -0.145 0.000 0.000 0.000 0.980 
Decane  0.156 -0.143 0.000 0.000 0.000 0.989 
Undecane  0.113 0.000 0.000 0.000 0.000 0.971 
Dodecane  0.053 0.000 0.000 0.000 0.000 0.986 
Hexadecane  0.000 0.000 0.000 0.000 0.000 1.000 
Cyclohexane  0.163 -0.110 0.000 0.000 0.000 1.013 
Methylcyclohexane  0.319 -0.215 0.000 0.000 0.000 1.012 
Isooctane  0.264 -0.230 0.000 0.000 0.000 0.975 
Benzene  0.107 -0.313 1.053 0.457 0.169 1.020 
Toluene  0.121 -0.222 0.938 0.467 0.099 1.012 
Fluorobenzene  0.181 -0.621 1.432 0.647 0.000 0.986 
Chlorobenzene  0.064 -0.399 1.151 0.313 0.171 1.032 
Bromobenzene  -0.064 -0.326 1.261 0.323 0.292 1.002 
Iodobenzene  -0.171 -0.192 1.197 0.245 0.245 1.002 
Nitrobenzene  -0.275 0.001 1.861 1.119 0.000 0.925 
Benzonitrile -0.062 -0.402 1.939 2.007 0.000 0.880 
Olive oil  -0.159 -0.277 0.904 1.695 -0.090 0.876 
Carbon disulfide  0.101 0.251 0.177 0.027 0.095 1.068 
Triolein  0.147 0.254 -0.246 1.520 1.473 0.918 
Methanol  -0.039 -0.338 1.317 3.836 1.396 0.773 
Ethanol  0.017 -0.232 0.867 3.894 1.192 0.846 
Propan-1-ol  -0.042 -0.246 0.749 3.888 1.078 0.874 
Butan-1-ol  -0.004 -0.285 0.768 3.705 0.879 0.890 
Pentan-1-ol -0.002 -0.161 0.535 3.778 0.960 0.900 
Hexan-1-ol -0.014 -0.205 0.583 3.621 0.891 0.913 
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Dry Solvent c e s a b l 
Heptan-1-ol -0.056 -0.216 0.554 3.596 0.803 0.933 
Octan-1-ol -0.147 -0.214 0.561 3.507 0.749 0.943 
Decan-1-ol -0.139 -0.090 0.356 3.547 0.727 0.958 
Propan-2-ol -0.048 -0.324 0.713 4.036 1.055 0.884 
Isobutanol -0.034 -0.387 0.719 3.736 1.088 0.905 
sec-Butanol -0.003 -0.357 0.699 3.595 1.247 0.881 
tert-Butanol 0.053 -0.443 0.699 4.026 0.882 0.907 
3-Methyl-1-butanol -0.052 -0.430 0.628 3.661 0.932 0.937 
Pentan-2-ol -0.031 -0.325 0.496 3.792 1.024 0.934 
Ethylene glycol -0.887 0.132 1.657 4.457 2.355 0.565 
2,2,2-Trifluoroethanol -0.092 -0.547 1.339 2.213 3.807 0.645 
Diethyl ether  0.288 -0.379 0.904 2.937 0.000 0.963 
Tetrahydrofuran 0.189 -0.347 1.238 3.289 0.000 0.982 
1,4-Dioxane -0.034 -0.354 1.674 3.021 0.000 0.919 
Dibutyl ether 0.153 -0.406 0.758 2.152 -0.610 1.008 
Methyl tert-butyl ether 0.231 -0.536 0.890 2.623 0.000 0.999 
Methyl acetate 0.129 -0.447 1.675 2.625 0.213 0.874 
Ethyl acetate  0.182 -0.352 1.316 2.891 0.000 0.916 
Butyl acetate 0.147 -0.414 1.212 2.623 0.000 0.954 
Propanone 0.127 -0.387 1.733 3.060 0.000 0.866 
Butanone 0.112 -0.474 1.671 2.878 0.000 0.916 
Cyclohexanone -0.086 -0.441 1.725 2.786 0.000 0.957 
Dimethylformamide -0.391 -0.869 2.107 3.774 0.000 1.011 
Dimethylacetamide -0.308 -0.736 1.802 4.361 0.000 1.028 
Diethylacetamide -0.075 -0.434 1.911 4.801 0.000 0.899 
Dibutylformamide -0.002 -0.239 1.402 4.029 0.000 0.900 
N-Methylpyrolidinone -0.128 -0.029 2.217 4.429 0.000 0.777 
N-Methyl-2-piperidone -0.264 -0.171 2.086 5.056 0.000 0.883 
N-Formylmorpholine -0.437 0.024 2.631 4.318 0.000 0.712 
N-Methylformamide -0.249 -0.142 1.661 4.147 0.817 0.739 
N-Ethylformamide -0.220 -0.302 1.743 4.498 0.480 0.824 
N-Methylacetamide -0.197 -0.175 1.608 4.867 0.375 0.837 
N-Ethylacetamide -0.018 -0.157 1.352 4.588 0.357 0.824 
Formamide -0.800 0.310 2.292 4.130 1.933 0.442 
Acetonitrile -0.007 -0.595 2.461 2.085 0.418 0.934 
Nitromethane -0.340 -0.297 2.689 2.193 0.514 0.728 
Dimethylsulfoxide -0.556 -0.223 2.903 5.036 0.000 0.719 
Tributylphosphate 0.097 -0.098 1.103 2.411 0.588 0.844 
Propylene carbonate -0.356 -0.413 2.587 2.207 0.455 0.719 
Gas-water -1.271 0.822 2.743 3.904 4.814 -0.213 
 
Table 2. Coefficients in Eqn. 6 for Correlating Solute Solubility in Dry Organic Solvents at 
298 K 
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Three specific conditions must be met in order to use the Abraham solvation parameter 
model to predict saturation solubilities. First, the same solid phase must be in equilibrium 
with the saturation solutions in the organic solvent and in water (i.e., there should be no 
solvate or hydrate formation). Second, the secondary medium activity coefficient of the solid 
in the saturated solutions must be unity (or near unity). This condition generally restricts the 
method to those solutes that are sparingly soluble in water and nonaqueous solvents. 
Finally, for solutes that are ionized in aqueous solution, CA,water, refers to the solubility of the 
neutral form. The second restriction may not be as important as initially believed. The 
Abraham solvation parameter model has shown remarkable success in correlating the 
solubility of several very soluble crystalline solutes. For example, Eqns 5 and 6 described the 
molar solubility of benzil in 24 organic solvents to within overall standard deviations of 
0.124 and 0.109 log units, respectively. Standard deviations for acetylsalicylic acid dissolved 
in 13 alcohols, 4 ethers and ethyl acetate were 0.123 and 0.138 log units. Benzil (Acree and 
Abraham, 2002) and acetylsalicylic acid (Charlton et al., 2003) exhibited solubilities 
exceeding 1Molar in several of the organic solvents studied. In the case of acetylsalicylic acid 
it could be argued that the model’s success relates back to when the equation coefficients 
were originally calculated for the dry solvents. The databases used in the regression 
analyses contained very few carboxylic acid solutes (benzoic acid, 2-hydroxybenzoic acid 
and 4-hydroxybenzoic acid). Most of the experimental data for carboxylic acids and other 
very acidic solutes was in the form of saturation solubilities, which were also in the 1 to 3 
Molar range. Such arguments do not explain why equations (5) and (6) described the 
measured benzil solubility data. The benzil solubilities were measured after most of the 
equation coefficients were first determined. 
4. High throughput experimental methods for measuring water-to-octanol 
partition coefficients 
Each administered drug has to pass several membrane barriers in order to be delivered to 
the desired target site for therapeutic action. Orally administered drugs have to be absorbed 
into the intestine. Transdermally administered drugs need to penetrate human skin. Drugs 
intended to act in the central nervous system must cross the blood-brain brain barrier (BBB). 
This barrier is formed by the endothelial cells of the cerebral capillaries and restricts the 
transport of many compounds into the brain from the blood stream. The cellular 
architecture of the human intestine, human skin and human brain are quite different; 
however, the principle of transcellular absorption is the same. The dissolved drug must be 
transferred from an aqueous environment into the membrane phase, must diffuse across the 
membrane, and afterwards must partition back into an aqueous-phase compartment. The 
water-to-octanol partition coefficient, Po/w, is widely regarded in the pharmaceutical 
industry as a quantitative measure for assessing a drug molecule’s affinity for the 
membrane phase. Considerable attention has been afforded to developing high throughput 
experimental methodologies that either directly measure Po/w values, or that enable accurate 
estimation of Po/w from other conveniently measured properties. Poole and Poole (2003) 
reviewed the direct and indirect separation for obtaining water-to-octanol partition 
coefficients, with emphasis on the high throughput methods. 
As selected examples of experimental methods that have been developed in recent years, 
Faller and coworkers (2005) designed a rather novel high throughput method to measure 
lipophilicity based on the diffusion of organic compounds between to aqueous phase 
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compartments separated by a thin 1-octanol liquid layer coated on a polycarbonate filter. 
The apparatus is shown in Figure 5. The molar concentration of the compound in the 
aqueous acceptor compartment, Cacceptor,end is measured at the end of the defined time 
endpoint, tend. The apparent membrane permeability, Papp, is calculated from Cacceptor,end by 
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where Vacceptor and Vdonor denote the aqueous phase volumes in the acceptor and donor 
compartments, respectively, Cdonor,initial refers to the initial compound concentration in the 
donor phase, and A is the membrane accessible surface area times porosity. The water-to-
octanol partition coefficient, Po/w, is derived from the measured apparent permeability 
using a calibration curve constructed from measured permeabilities of standard compounds 
of known Po/w values. The assay has been used to measure water-to-hexadecane partition 
coefficients (Wohnsland and Faller, 2001) and can be performed using 96-well microtiter 
plates.  
 
 
Fig. 5. High throughput experimental method for measuring water-to- octanol partition 
coefficients based on the diffusion of a solute betweentwo aqueous phase compartments. 
Gao et al. (2005) developed a miniaturized method involving the dispersion of colloidal stable 
porous silica-encapsulated magnetic nanoparticles into water and/or an aqueous-buffered 
solution. Prior to dispersion, the nanoparticles are preloaded with a known amount of 1-
octanol. Equilibrium is quickly established between the drug dissolved in the aqueous (or 
aqueous-buffered) solution and the small octanol droplets on the nanoparticles. The 
paramagnetic properties of the nanoparticles facilitate magnetic-induced phase separation. 
Once the magnetic particles are removed, the uv/visible absorbance of the solution is 
recorded. The log Po/w (or log Do/w in the case of an ionic solute) is calculated as 
 /
tan
log log [( )( )]
before after aqueous
o w
after oc ol
Abs Abs V
P
Abs V
  (9) 
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where Absbefore and Absafter refer to the measured uv/visible absorbance of the aqueous 
solution prior and after partitioning, respectively, and Vaqueous/Voctanol is the ratio of the 
aqueous phase volume divided by the volume of the octanol phase. 
Henchoz and coworkers (2010) determined the water-to-octanol partition coefficients of 21 
acidic and 29 basic pharmaceutical compounds using microemulsion electrokinetic capillary 
chromatography (MEEKC) coupled with uv absorption and mass spectrometric detection. 
The method involves measuring the retention factor of the investigated compound 
 
, ,
,
,
,
( )
(1 )
r solute r eof
solute
r solute
r eof
r mc
t t
k
t
t
t


 (10) 
where tr,solute, tr,eof and tr,mc are the retention/migration times of the investigated drug 
compound, a highly hydrophilic neutral marker (such as dimethyl sulfoxide) and a highly 
lipophilic pseudostationary phase marker (such as dodecanophenone or 1-phenyldodecane). 
The migration times of the two markers define the migration window. The log Po/w of the 
drug molecules are obtained from a calibration curve 
 log ksolute = slope · log Po/w + intercept (11) 
established with the measured retention factors of standard compounds with known log 
Po/w values. The proposed method was validated using a set of 35 well-balanced reference 
compounds that contained neutral, acidic (pKa > 3.6) or basic (pKa < 5.5) compounds with 
log Po/w values ranging from 0.7 to 4.8. The acidic compounds were analyzed at a pH = 2, 
while the neutral and basic compounds were analyzed at pH = 10.  The authors found that 
the log Po/w values based on MEEKC method differed by less than 0.5 log units from the log 
Po/w values determined by the more traditional shake-flask method. The method allowed 
log Po/w measurement in less than 20 minutes, which is acceptable for quick screening 
methods. The authors further noted that the MEEKC method could be easily automated, 
consumed very little sample and solvent, and did not require a highly purified drug sample. 
Logarithms of the water-to-organic solvent partition coefficients represent another solute 
property that has been successfully correlated by Eqn. 12 of the Abraham solvation 
parameter model. 
 Log P = c + e · E + s · S + a · A + b · B + v · V (12) 
In Table 3 we have compiled the equation coefficients that have been reported describing 
the various water-to-organic solvent partitioning systems that have been studied. In the case 
of the alkane and chloroalkane (dichloromethane, trichloromethane, tetrachloromethane, 
1,2-dichloroethane and 1-chlorobutane) solvents, one will note that the equation coefficients 
for describing log P are identical to the coefficients for correlating the log molar solubility 
ratios, log (CA,organic/CA,water) values. As noted previous the molar solubility ratios describe a 
“hypothetic partitioning” processes for solute transfer to an anhydrous “dry” organic 
solvent. Solubility ratios and practical partition coefficients are nearly identical for solvents 
that are almost “completely” immiscible with water.  
Water-organic solvent based biphasic systems are widely used in liquid-liquid extraction and 
in calculating Abraham model solute descriptors in accordance with Eqn. 12. For compounds 
that react with water, or for compounds that have very low aqueous solubilities, water-based  
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Wet Solvent c e s a b v 
Butan-1-ola 0.376 0.434 -0.718 -0.097 -2.350 2.682 
Pentan-1-ola 0.185 0.367 -0.732 0.105 -3.100 3.395 
Hexan-1-ola -0.006 0.460 -0.940 0.142 -3.284 3.792 
Heptan-1-ola 0.041 0.497 -0.976 0.030 -3.438 3.859 
Octan-1-ola 0.088 0.562 -1.054 0.034 -3.460 3.814 
Nonan-1-ola -0.041 0.562 -1.103 0.090 -3.540 3.922 
Decan-1-ola -0.136 0.542 -0.989 0.046 -3.722 3.996 
Isobutanola 0.249 0.480 -0.639 -0.050 -2.284 2.758 
Olely alcohol a -0.096 0.148 -0.841 -0.438 -4.040 4.125 
Dichloromethane  0.319 0.102 -0.187 -3.058 -4.090 4.324 
Trichloromethane  0.191 0.105 -0.403 -3.112 -3.514 4.395 
Tetrachloromethane  0.199 0.523 -1.159 -3.560 -4.594 4.618 
1,2-Dichloroethane  0.183 0.294 -0.134 -2.801 -4.291 4.180 
1-Chlorobutane  0.222 0.273 -0.569 -2.918 -4.883 4.456 
Butane  0.297 -0.005 -1.584 -3.188 -4.567 4.562 
Pentane  0.369 0.386 -1.568 -3.535 -5.215 4.514 
Hexane  0.361 0.579 -1.723 -3.599 -4.764 4.344 
Heptane  0.325 0.670 -2.061 -3.317 -4.733 4.543 
Octane  0.223 0.642 -1.647 -3.480 -5.067 4.526 
Nonane  0.240 0.619 -1.713 -3.532 -4.921 4.482 
Decane  0.160 0.585 -1.734 -3.435 -5.078 4.582 
Undecane  0.058 0.603 -1.661 -3.421 -5.120 4.619 
Dodecane  0.114 0.668 -1.664 -3.545 -5.006 4.459 
Hexadecane  0.087 0.667 -1.617 -3.587 -4.869 4.433 
Cyclohexane  0.159 0.784 -1.678 -3.740 -4.929 4.577 
Methylcyclohexane  0.246 0.782 -1.982 -3.517 -4.293 4.528 
Isooctane  0.318 0.555 -1.737 -3.677 -4.864 4.417 
Benzene  0.142 0.464 -0.588 -3.099 -4.625 4.491 
Toluene  0.143 0.527 -0.720 -3.010 -4.824 4.545 
Fluorobenzene  0.139 0.152 -0.374 -3.030 -4.601 4.540 
Chlorobenzene  0.065 0.381 -0.521 -3.183 -4.700 4.614 
Bromobenzene  -0.017 0.436 -0.424 -3.174 -4.558 4.445 
Iodobenzene  -0.192 0.298 -0.308 -3.213 -4.653 4.588 
Nitrobenzene  -0.152 0.525 0.081 -2.332 -4.494 4.187 
Diethyl ethera 0.248 0.561 -1.016 -0.226 -4.553 4.075 
Diisopropyl ethera 0.472 0.413 -0.745 -0.632 -5.251 4.059 
Dibutyl ether 0.252 0.677 -1.506 -0.807 -5.249 4.815 
o-Nitrophenyl octyl ether 0.121 0.600 -0.459 -2.246 -3.879 3.574 
Ethyl acetatea 0.441 0.591 -0.699 -0.325 -4.261 3.666 
Butyl acetatea -0.475 0.428 -0.094 -0.241 -4.151 4.046 
PGDPb 0.256 0.501 -0.828 -1.022 -4.640 4.033 
Methyl isobutyl ketone 0.383 0.801 -0.831 -0.121 -4.441 3.876 
Olive oil  -0.035 0.574 -0.798 -1.422 -4.984 4.210 
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Carbon disulfide  0.047 0.686 -0.943 -3.603 -5.818 4.921 
Isopropyl myristate  -0.605 0.930 -1.153 -1.682 -4.093 4.249 
Triolein  0.385 0.983 -2.083 -2.007 -3.452 4.072 
a Correlation uses the Bo solute descriptor. 
b Propylene glycol dipelargonate. 
Table 3. Coefficients in Eqn. 12 for Correlating Solute Water-to-Organic Solvent log P values 
at 298 K 
 
Wet Solvent c e s a b l 
Butan-1-ol -0.095 0.262 1.396 3.405 2.565 0.523 
Pentan-1-ol -0.107 -0.001 1.188 3.614 1.671 0.721 
Hexan-1-ol -0.302 -0.046 0.880 3.609 1.785 0.824 
Heptan-1-ol -0.159 0.018 0.825 3.539 1.425 0.830 
Octan-1-ol -0.198 0.002 0.709 3.519 1.429 0.858 
Nonan-1-ol -0.197 0.141 0.694 3.616 1.299 0.827 
Decan-1-ol -0.302 0.233 0.741 3.531 1.177 0.835 
Isobutanol -0.095 0.262 1.396 3.405 2.565 0.523 
Olely alcohol  -0.268 -0.392 0.800 3.117 0.978 0.918 
Dichloromethane  0.192 -0.572 1.492 0.460 0.847 0.965 
Trichloromethane  0.157 -0.560 1.259 0.374 1.333 0.976 
Tetrachloromethane  0.217 -0.435 0.554 0.000 0.000 1.069 
1,2-Dichloroethane  0.017 -0.337 1.600 0.774 0.637 0.921 
1-Chlorobutane  0.130 -0.581 1.114 0.724 0.000 1.016 
Butane  0.291 -0.360 0.091 0.000 0.000 0.959 
Pentane  0.335 -0.276 0.000 0.000 0.000 0.968 
Hexane  0.292 -0.169 0.000 0.000 0.000 0.979 
Heptane  0.275 -0.162 0.000 0.000 0.000 0.983 
Octane  0.215 -0.049 0.000 0.000 0.000 0.967 
Nonane  0.200 -0.145 0.000 0.000 0.000 0.980 
Decane  0.156 -0.143 0.000 0.000 0.000 0.989 
Undecane  0.113 0.000 0.000 0.000 0.000 0.971 
Dodecane  0.017 0.000 0.000 0.000 0.000 0.989 
Hexadecane  0.000 0.000 0.000 0.000 0.000 1.000 
Cyclohexane  0.163 -0.110 0.000 0.000 0.000 1.013 
Methylcyclohexane 0.318 -0.215 0.000 0.000 0.000 1.012 
Isooctane  0.264 -0.230 0.000 0.000 0.000 0.975 
Benzene  0.107 -0.313 1.053 0.457 0.169 1.020 
Toluene  0.121 -0.222 0.938 0.467 0.099 1.012 
Fluorobenzene  0.181 -0.621 1.432 0.647 0.000 0.986 
Chlorobenzene  0.064 -0.399 1.151 0.313 0.171 1.032 
Bromobenzene  -0.064 -0.326 1.261 0.323 0.292 1.002 
Iodobenzene  -0.171 -0.192 1.197 0.245 0.245 1.002 
Nitrobenzene  -0.296 0.092 1.707 1.147 0.443 0.912 
Benzonitrile -0.067 -0.257 1.848 2.009 0.227 0.870 
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Diethyl ether 0.206 -0.169 0.873 3.402 0.000 0.882 
Dipropyl ether 0.065 -0.202 0.776 3.074 0.000 0.948 
Diisopropyl ether 0.114 -0.032 0.685 3.108 0.000 0.941 
Dibutyl ether 0.369 -0.216 0.026 2.626 -0.499 1.124 
Ethyl acetate 0.130 0.031 1.202 3.199 0.463 0.828 
Butyl acetate -0.664 0.061 1.671 3.373 0.824 0.832 
Methyl isobutyl ketone 0.244 0.183 0.987 3.418 0.323 0.854 
Olive oil  -0.156 -0.254 0.859 1.656 0.000 0.873 
Carbon disulfide  0.101 0.251 0.177 0.027 0.095 1.068 
Triolein  0.147 0.254 -0.246 1.520 1.473 0.918 
Table 4. Coefficients in Eqn. 2 for Correlating Solute Gas-to-Organic Solvent log K values at 
298 K 
partitioning systems may not be appropriate. Poole and coworkers (Karunasekara and Poole, 
2010; Qian and Poole, 2007; Ahmed and Poole, 2006a,b) have reported Abraham model 
correlations for several totally organic biphasic systems, such as heptane + formamide, hexane 
+ acetonitrile, heptane + methanol, heptane + N,N-dimethylformamide, heptane + 2,2,2-
trifluoroethanol, and heptane + 1,1,1,3,3,3-hexafluoroisopropanol. The organic-based biphasic 
systems allow one to calculate solute descriptors for compounds that might not otherwise be 
possible with water-based partitioning systems. For example, the biphasic hexane + 
acetonitrile, heptane + N,N-dimethylformamide, and heptane + 2,2,2-trifluoroethanol systems 
were used, in combination with chromatographic retention factors, to determine a complete 
set of descriptors for organosilicon compounds (Atapattu and Poole, 2009; Ahmed et al., 2007), 
many of which react with water. Abraham model equation coefficients are tabulated in Table 5 
for seven organic solvent-to-organic solvent partitioning systems.  
 
Partitioning system c e s a b v 
Formamide-to-heptane 0.083 0.559 -2.244 -3.250 -1.614 2.384 
N,N-Dimethylformamide-to-heptane 0.065 0.030 -1.405 -2.039 -0.806 0.721 
2,2,2-Trifluoroethanol-to-heptane 0.160 0.856 -1.538 -1.325 -2.965 1.190 
1,1,1,3,3,3-Hexafluoroisopropanol-to-heptane -0.225 0.720 -1.357 -0.577 -2.819 1.161 
Methanol-to-heptane -0.056 0.164 -0.620 -1.337 -0.957 0.507 
Ethylene glycol-to-heptane 0.343 0.000 -1.247 3.807 -2.194 2.065 
Acetonitrile-to-hexane 0.097 0.189 -1.332 -1.649 -0.966 0.773 
Table 5. Coefficients in Eqn. 12 for Correlating Solute Organic Solvent-to-Organic Solvent 
log P values at 298 K 
5. Calculation of Abraham solute descriptors from measured solubility and 
partition coefficient data 
The application of Eqn. 1 and Eqn. 2 requires a knowledge of the descriptors (or properties) 
of the solutes: E, S, A, B, V and L. The descriptors E and V are quite easily obtained. V can 
be calculated from atom and bond contributions as outlined previously (Abraham and 
McGowan, 1987). The atom contributions are in Table 6; note that they are in cm3 mol -1. The 
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bond contribution is 6.56 cm3 mol -1 for each bond, no matter whether single, double, or 
triple, to be subtracted. For complicated molecules it is time consuming to count the number 
of bonds, Bn, but this can be calculated from the algorithm given by Abraham (1993a) 
 Bn = Nt -1 + R   (13)  
where Nt is the total number of atoms in the molecule and R is the number of rings. 
Once V is available, E can be obtained from the compound refractive index at 20oC. If the 
compound is not liquid at room temperature or if the refractive index is not known the latter 
can be calculated using the freeware software of Advanced Chemistry Development (ACD). 
An Excel spreadsheet for the calculation of V and E from refractive index is available from 
the authors. Since E is almost an additive property, it can also be obtained by the summation 
of fragments, either by hand, or through a commercial software program (ADME Boxes, 
2010). There remain the descriptors S, A, B, and L to be determined.  
Partition coefficients and/or solubilities can be used to obtain all the four remaining 
descriptors (Abraham et al., 2004). Suppose there are available solubilities for a given 
compound in water and a number of solvents. Then solubility ratios, log (CA,organic/CA,water), 
can be obtained as shown in Eqn. 5 and Eqn. 6. If three solubility ratios are available for 
three solvent systems shown in Table 1, we have three equations and three unknowns (S, A, 
and B) so that the latter can be determined. Of more practical use is a situation where 
several solubility ratios are known. Then if we have, say, six solubility ratios and three 
equations, the three unknowns can be obtained as the descriptors that give the best fit to the 
six equations. The Solver add-on program to Excel can be set up to carry out such a 
calculation automatically. However, it is possible to increase the number of equations by the 
stratagem of converting the water-to-solvent solubility ratios into gas to solvent solubility 
ratios, CA,organic/CA,gas 
 CA,organic/CA,water * CA,water/CA,gas    =   CA,organic/CA,gas  (14)  
The ratio CA,water/CA,gas is the gas-to-water partition coefficient, usually denoted as Kw. A 
further set of equations is available for gas-to-solvent solubility ratios, Table 2. Thus six 
water-to-solvent solubility ratios can be converted into six gas-to-solvent solubility ratios, 
leading to a set of 12 equations. If logKw is not known, it can be used as another parameter 
to be determined. This increases the number of unknowns from four (S, A, B, L) to five (S, 
A, B, L, logKw) but the number of equations is increased from six to twelve. In addition, two 
equations are available for gas to solvent partitions themselves, see the last entries in Tables 
1 and 2, making for the present case no fewer than fourteen equations. 
As an example, we use data on solubilities of trimethoprim in eight solvents (Li et al., 2008) 
converted from mol fraction to mol dm-3. The solubility in water was not given, but is 
known to be 2.09* 10-3 in mol dm-3 (Howard and Meylan, 1997). The eight observed 
solubility ratios, CA,organic/CA,water, are in Table 7, as log (ratio). We took log Kw as another 
parameter to be determined, leading to no less than 18 equations: the eight original 
equations from solubilities in the eight solvents that led to CA,organic/CA,water, the 
corresponding eight equations for CA,organic/CA,gas, and two equations for CA,water/CA,gas (ie 
Kw). With E fixed at 1.892 and V fixed at 2.1813, the best fit values of the descriptors were S 
= 2.52, A = 0.44, B = 1.69, L = 11.81 and log Kw = 14.49; these yielded the calculated log 
(ratios) in Table 7. For all 18 values, the Average Error = -0.002, the Absolute Average Error 
= 0.092, the RMSE = 0.107, and the SD = 0.110 log unit.  Not only do the original solubilities 
allow the derivation of descriptors for trimethoprim, but the latter, in turn, allow the 
prediction of solubility ratios and hence actual solubilities in all the solvents listed in Table 1. 
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Exactly the same procedure is adopted if actual partition coefficients are experimentally 
available, rather than solubilities. The relevant equations are now those in Table 3 and Table 4. 
Of course if both solubilities and actual partition coefficients have both been experimentally 
determined, a combination of equations from Tables 1 and 2 and from Tables 3 and 4 can be 
used. Even though partition coefficients refer to partition into wet solvents, descriptors 
obtained from partition coefficients using equations in Table 3 and Table 4 can still be used to 
predict solubility ratios and solubilities in dry solvents for all the solvents listed in Table 1. 
 
 
C 16.35  N 14.39  O 12.43 
Si 26.83 P 24.87 S 22.91 
Ge 31.02 As 29.42 Se 27.81 
Sn 39.35 Sb 37.74 Te 36.14 
Pb 43.44 Bi 42.19   
      
H 8.71 He 6.76 B 18.32 
F 10.48 Ne 8.51 Hg 34.00 
Cl 20.95 A 1.90   
Br 26.21 Kr 2.46   
I 34.53 Xe 3.29   
  Rn 3.84   
Table 6. Atom contributions to the McGowan volume, in cm3 mol-1 
 
Water-to-solvent calc obs 
Methanol 1.35 1.48 
Ethanol 0.98 0.94 
Propanol 0.75 0.80 
Butanol 0.53 0.68 
2-Propanol 0.61 0.51 
2-Butanol 0.65 0.62 
Tetrahydrofuran 1.18 1.02 
Propanone 0.90 0.94 
Gas to water 14.48 14.49 
   
Gas-to-solvent calc obs 
Methanol 15.81 15.97 
Ethanol 15.48 15.43 
Propanol 15.23 15.29 
Butanol 15.02 15.18 
2-Propanol 15.14 15.01 
2-Butanol 15.18 15.11 
Tetrahydrofuran 15.70 15.51 
Propanone 15.34 15.43 
Gas to water 14.53 14.49 
Table 7. Solubility ratios for trimethoprim, as log (ratio) 
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Although we have set out the determination of descriptors from experimental measurements, 
it is still very helpful to use the ACD software (ADME Boxes, 2010) to calculate the descriptors 
at the same time. Occasionally there may be erroneous solubility measurements, or solubilities 
may be affected through solvate formation, and the calculated descriptors afford a useful 
check on the obtained descriptors from experiment measurements.  
6. Abraham solvation parameter model: prediction of blood-to-brain and 
blood-to-iissue partition coefficient 
Successful drug development requires efficient delivery of the drug to the target site. The 
drug must cross various cellular barriers by passive and/or transporter-mediated uptake. 
Drug delivery to the brain is particularly challenging as there are two physiologically 
barriers – the blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSFB) – 
separating the brain from its blood supply controlling the transport of chemical compounds. 
The BBB is a continuous layer of microvessel endothelial cells, connected by highly-
developed tight junctions, which effectively restrict paracellular transport of molecules 
irrespective of their molecular size. Tight junctions provide significant transendothelial 
electrical resistance to the brain microvessel endothelial cells and serves to further impede 
the penetration of the BBB. The electrical resistance between the endothelial cells is on the 
order of 1500 – 2000 Ω/cm2, as compared to and electrical resistance of 3.33 Ω/cm2 found in 
other body tissues (Alam et al., 2010). Under normal conditions the BBB acts as a barrier to 
toxic agents and safeguards the integrity of the brain. A compound may circumvent the BBB 
and gain access to the brain by the nose-to-brain route. The compound is transported to the 
brain via an olfactory pathway following absorption across the nasal mucosa.  
Alternatively, compounds may permeate from the blood into the cerebrospinal fluid and 
permeate into the brain interstitial fluid. The BCSFB separates the blood from the 
cerebrospinal fluid (CSF) that runs in the subarachnoid space surrounding the brain. The 
BCSFB is located at the choroid plexus, and it is composed of epithelial cells held together at 
their apices by tight junctions, which limit paracellular flux. Hence compounds penetrate the 
barrier transcellularly. The CSF-facing surface of the epithelial cells, which secrete CSF into the 
ventricles, is increased by the presence of microvilli. The capillaries in the choroid plexus allow 
free movement of molecules via fenestractions and intracellular gaps. Transport across the 
BCSFB is not an accurate measure of transport across the BBB as the two barriers are 
anatomically different. However, as Begley et al. (2000) point out, for many compounds there is 
a permanently maintained concentration gradient between brain interstitial fluid and the CSF. 
The transport of compounds into the brain can take place through ‘passive’ transport or 
‘active’ transport. Nearly all the calculational models for transport into the brain deal with 
passive transport, although it is now known that many compounds are prevented from 
crossing the BBB through efflux mechanisms especially involving P-glycoprotein. The use of 
wildtype mice and knockout mice (the latter deficient in Pgp) has shown conclusively that 
for a number of drugs the brain to plasma distribution is much lower for the wildtype mice 
than for knockout mice. We will focus on passive transport, but it must be appreciated that 
any analysis might well include compounds that are actually subject to active transport and 
will appear as outliers in the analyses. 
The steady-state distribution of a compound between the blood (or plasma) and brain, and 
the rate of permeation of a compound from blood (or from an aqueous saline solution) 
through the blood brain barrier, are two quantitative measures of drug uptake in the brain. 
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The logarithm of the blood-to-brain concentration ratio, log BB, is a thermodynamic 
quantity defining the extent of blood penetration. The log BB is mathematically given by 
 ,
,
log ( )solute brain
solute blood
C
BB
C
  (15) 
the ratio of the solute concentration in brain tissue divided by the solute’s concentration in 
blood (or serum or plasma) at steady-state conditions. The blood/brain distribution ratio 
can be experimentally determined by intravenous administration of a single injection of 14C-
radioactive isotope labeled test substance in rats. The animal is sacrificed at a specified time 
endpoint after equilibrium is achieved. The brain and blood are immediately harvested, and 
the concentration in each biological sample is quantified from the measured radioactivity. 
Isotopic labeling provides a convenient means to distinguish the injected test substance from 
all other chemicals that might be present in the body. Radioactive counting methods do not 
distinguish between the radioactive isotope in the injected test substance and any 
degradation products that might have been formed before the animal was sacrificed. The 
distribution experiments are usually carried out over a long time scale, possibly hours, and 
concentrations in blood and brain obtained as a function of time. The ratio, as Eq. 15, will 
change with time and only if it reaches a constant value can the ratio be taken as an 
equilibrium value. This is very time consuming indeed, as only one measurement can be 
made with each rat. Despite these shortcomings, radioactive labeling is one of the more 
popular methods for not only determining the blood-to-brain distribution coefficient, but 
other blood-to-tissue partition coefficients as well. 
Blood-to-brain and blood-to-tissue partition coefficients have also been measured for 
volatile organic compounds using the in vitro vial method (see Figure 6). A known amount 
of animal sample is placed in a glass vial of known volume. The vial is then sealed and a 
minute known quantity of the volatile organic compound (VOC) is introduced by syringe 
through the rubber septum. After equilibration a sample of the headspace vapor phase is 
withdrawn from the glass vial for gas chromatographic analysis. The gas-to-tissue partition 
coefficient is computed from mass balance considerations as the total amount of solute 
added, the concentration of the vapor phase, the headspace volume and amount of tissue 
sample are all known. The blood-to-tissue partition coefficient, Ptissue/blood, is calculated as  
 , ,/ / /
, ,
( ) ( )solute tissue solute airtissue blood tissue air air blood
solute air solute blood
C C
P P xP x
C C
   (16) 
the product of the measured air-to-tissue partition coefficient, Ptissue/air, times the measured 
blood-to-air partition coefficient, Pair/blood. The in vitro partition coefficient data are 
important and are used as required input parameters in pharmacokinetic models developed 
to determine the disposition of volatile organic compounds that individuals inhale in the 
workplace and in the environment. 
Abraham and coworkers (2006a) reported correlation models for the air-to-brain (Pbrain/air) 
and blood-to-brain (Pbrain/blood) partition coefficients for VOCs in humans and rats 
 
 
 
brain/air
2
Log P     0.987  0.263  0.411  3.358  2.025  0.591  
        N  81,  R  0.923,  SD  0.346,  RMSE  0.333,  F  179.0
in vitro       
    
E S A B L
 (17) 
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 
 
brain/blood
2
Log BB  Log P    0.057  0.017 –  0.536 –  0.323 –  0.335  0.731
N  78,  R  0.725,  SD  0.203,  RMSE  0.196,  F  37.9
in vitro    
    
E S A B V
 (18) 
 
 
Fig. 6. Equilibrium vial technique depicting removal of the equilibrated headspace vapor 
above the animal/human tissue 
In Eqns. 17 and 18, N is the number of data points in the regression analysis, R2 represents the 
squared correlation coefficient, SD denotes the standard deviation and RMSE corresponds to 
the root mean square error. Note that in a multiple linear regression equation, the denominator 
in the definition of SD is N – P – 1 and in the definition of RMSE it is N – P, where P is the 
number of independent variables in the equation. The derived correlations provided a 
reasonably accurate mathematical description of the observed partition coefficient data as 
evidenced by the high squared correlation coefficients and reasonably small standard 
deviations. Both correlations were validated using training set and test set analyses. In 
comparing calculated biological data to observed values one must remember that the 
measured values do have larger experimental uncertainties. A reasonable estimated 
uncertainty for the measured log Pbrain/air would be about 0.2 log units based on independent 
values from different laboratories. Rat and human partition coefficient data for each given 
VOC were averaged (if both values were available), and the average values were combined 
into a single regression analysis. In a comparison of experimental human and rat partition 
coefficient data for 17 common compounds, the authors had shown that the two sets of data 
(human versus rat) differed by only 0.062 log units, which is likely less than the experimental 
uncertainty associated with the measured experimental values. For the compounds studied, 
human and rat partition coefficient data were identical for all practical purposes. The authors 
also showed that blood-to-brain and plasma-to-brain partition coefficients were sufficiently 
close and could be combined into a single Abraham model correlation 
 
brain/(blood,plasma)
2
log P   0.028  0.003  –  0.485  –  0.117  – 0.408   0.703 
   N  99,  R  0.703,  SD  0.197,  RMSE  0.191,  F  44.1
   
    
E S A B V
 (19) 
Eqs. (18) and (19), are not substantially different, and the statistics are almost the same. It is a 
moot point as to whether further values of blood to brain partition coefficients should best 
be predicted through Eqn. 18 or 19. We recommend that Eqn. 18 be used to predict blood-to-
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brain partition coefficients of VOC because it refers specifically to blood rather than to blood 
or plasma. 
A follow-up study (Abraham et al., 2006b) considered the partitioning behavior of drugs and 
drug candidates (measured by in vivo experimental methods), as well as the VOC in vitro 
partition coefficient data discussed above. The Abraham model correlation for the in vivo log 
Pbrain/blood data 
 
 
brain/blood
2
log BB  log P    0.547  0.221 –  0.604 –  0.641 –  0.681  0.635  – 1.216   
  N  233, R  0.75, SD  0.33,  F  113
in vivo   
   
E S A B V Ic
(20) 
differs from the correlation equation for the VOCs (see Eqn. 18). In particular, the c-coefficients 
differ appreciably 0.547 (SD = 0.078) as against -0.024 (SD=0.069), which suggests that there is a 
systematic difference between the in vivo and in vitro distributions. The authors went on to 
show that the difference resulted in part because the two sets of compounds (drugs versus 
VOCs) inhabit different areas in chemical space. The in vivo drug compounds had much larger 
solute descriptors, and included compounds having a carboxylic acid functional group. The 
independent variable Ic was needed as an indicator descriptor for carboxylic acids (Ic = 1 for 
carboxylic acids, Ic = 0 for noncarboxylic acid solutes). 
The blood-to-brain partition coefficient provides valuable information regarding a 
compound’s ability to penetrate the blood-brain barrier. Cruciani et al. (2000) noted that 
compounds having log BB values greater than 0.0 (concentration in the brain exceeds 
concentration in the blood) should cross the barrier, whereas compounds having log BB less 
than -0.3 tended not to cross the barrier. Li and coworkers (2005) used a slightly different 
classification scheme (see Figure 7) of dividing compounds into BBB-penetrating (BBB+) or 
BBB-non-penetrating (BBB-) according to whether the log BB value was ≥ -1 or ≤ -1, 
respectively. Many times an actual numerical log BB is not needed in the decision making 
process, and in such cases, an indication of BBB+ or BBB- is often sufficient. Zhao et al. (2007) 
proposed a fairly simple decision tree for classifying drug candidates as BBB+ or BBB- based 
on their Abraham solute descriptors (See Figure 7). Solute acidity and solute basicity were 
the two most important properties governing BBB penetration, with solute excess molar 
refraction playing a much smaller role. The proposed classification scheme correctly 
predicted the BBB penetration of 90 % of the 1093 compounds considered.  
As noted above permeation of a compound from blood (or from an aqueous saline solution) 
through the blood brain barrier can be used to indicate drug uptake in the brain. The 
membrane permeability-surface area product, PS, is a kinetic parameter used in describing 
initial rate of unidirectional transfer  
 /(1 )PS Fink F e
   (21) 
where kin is the measured transfer constant and F is the perfusion fluid flow expressed in 
milliliters per second per gram. For solutes that bind rapidly and reversibly to plasma 
proteins, Eqn. 21 is modified as follows 
 /(1 )fu PS Fink F e
   (22) 
assuming that the unbound and bound forms of the drug are in equilibrium in the fluid. In 
Eqn. 22, fu is the fraction of the unbound drug in the perfusion fluid. In a typical experiment, 
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the drug (dissolved in blood or in an aqueous saline solution) is perfused into the internal 
carotid artery and the rate of drug uptake is determined by a radioisotope assay method. The 
animals are sacrificed at various time intervals. The time scale needed to perform the perfusion 
study is very short – typically no more than a few minutes. Because of the small time scale, 
perfusion measurements are less subject to degradation effects than are log BB measurements, 
although the same difficulties over passive and active transport still exist. 
 
 
Fig. 7. Decision tree for predicting whether drugs pass through the BBB based on their 
Abraham solute descriptors. BBB+ indicates BBB penetrating whereas BBB- denotes BBB 
non-penetration. The right-handside of any decision branch is no penetration (red box), and 
the left-handside is yes penetration (green box). (The right-hand side of any decision branch 
is yes, and the left-hand side is no.) 
 
Abraham (2004) derived the following mathematical correlation  
  2
log PS  0.716 –  0.974 –  1.802 –  1.603  1.893      
 N  30,  R  0.868,  SD  0.52,  F  42  
  
   
S A B V
 (23) 
by regression analysis of the experimental log PS data for 30 neutral compounds from 
protein-free saline solution buffered at pH of 7.4. The contribution of the e · E term was not 
significant and was removed from Eqn. 23. The negative equation coefficients in Eqn. 23 
indicate that an increase in compound polarity of any kind, that is dipolarity/polarizability, 
hydrogen-bonding acidity or hydrogen-bonding basicity, results in a decrease in the rate of 
permeation. Increased solute size (V solute descriptor), on the other hand, results in a 
greater permeation rate. 
The Abraham model correlations that have been presented thus far pertain to neutral 
molecules. The basic model has been extended to include processes between condensed 
phases involving ions and ionic species 
 SP  c  e ·  s ·  a ·  b ·  v ·  j ·  j ·         E S A B V J J  (24) 
by adding one new term for cations and one new term for anions. J+ is used whenever a 
cation is the solute, J- whenever an anion is the solute, and neither is used whenever the 
solute is a nonelectrolyte. It is very important to note that the two new ionic descriptors 
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are used together with the descriptors originally chosen for nonelectrolytes. This ensures 
that values of S, A and B for ions and ionic species are on the same scale as those for 
nonelectrolytes. Solute descriptors have been reported for many simple cations and 
anions, for carboxylates, for phenoxides, and for protonated amines and protonated 
pyridines. The j+ and j- equation coefficients have been determined (Abraham and Acree, 
2010a,b,c,d) for several of the organic solvents listed in Table 1. Abraham (2011) recently 
reanalyzed the published log PS data in terms of Eqn. 24 to yield the following correlation 
model 
  2
log PS  1.268 –  0.047 –  0.876 –  0.719 –  1.571  1.767  0.469  1.663   
 N  88,  R  0.810,  SD  0.534,  F  48.8   
     
   
E S A B V J J
(25) 
The 88 log PS values in Eqn. 25 were for compounds that existed in the saline perfusate 
entirely (or almost entirely) as neutral molecules or entirely (or almost entirely) as charged 
species, and which underwent perfusion by a passive process. Abraham showed that log PS 
values for carboxylate anions are about two log units less than those for the neutral 
carboxylic acids, and that log PS values for protonated base cations are about one log unit 
less than those for the neutral bases. 
7. Abraham solvation parameter model: prediction of blood-to-tissue and 
gas-to-tissue partition coefficients 
Air-to-blood partitioning is a major determinant governing the uptake of chemical vapors 
into the blood and their subsequent elimination from blood to exhaled air. Air partitioning 
processes are becoming increasing more important in the pharmaceutical industry given the 
large numbers of drugs and vaccines that are now administered by inhalation aerosols and 
nasal delivery devices. Inhalation drug delivery is appealing given the large surface area for 
drug absorption, the high blood flow to and from the lung, and the absence of first pass 
metabolism that is characteristic of the lung. Inhalation drug delivery results in both a rapid 
clearance action and a rapid onset of therapeutic action, and a reduction in the number of 
undesired side effects. Eixarch and coworkers (2010) proposed the development of a 
pulmonary biopharmaceutical classification system (pBCS) that would classify drugs 
according to their ability to reside in the lung or to be transferred to the bloodstream. The 
classification scheme would need to consider factors associated with the lung’s biology 
(metabolism, efflux transporters, clearance) and with the drug formulation/physicochemical 
properties (solubility, lipophilicity, protein binding, particle size, aerosol physics). Blood-to-
tissue partitionings govern the distribution throughout the rest of the body once the drug 
has entered the bloodstream. 
Abraham model correlations have been developed to describe the air-to-tissue and blood-to-
tissue partition coefficients of drugs and volatile organic compounds (VOCs). The derived 
mathematical equations include: 
Muscle (Abraham et al., 2006c): 
 
 muscle/air
2
logK    1.039  0.207  0.723  3.242  2.469  0.463    
(N  114,  R  0.944,  SD  0.267,  F  363
in vitro       
    
E S A B L
 (26) 
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 
 
muscle/blood
2
log P    0.185 –  0.209 –  0.593 –  0.081 –  0.168  0.741   
N  110,  R  0.537,  SD  0.207,  F  24
in vitro   
   
E S A B V
 (27) 
 
 
 
muscle/blood
2
log P   0.082 –  0.059  0.010 –  0.248  0.028 B  0.110 –  1.022  
N  60,  R   0.745,  SD  0.253,  F  25.9  
in vivo   
   
E S A V Ic
(28) 
Fat (Abraham and Ibrahim, 2006): 
 
 
 
fat/air
2
logK    0.052  0.051  0.728  1.783  0.332  0.743  
N  129,  R  0.958,  SD  0.194,  F  562.8
in vitro       
   
E S A B L
 (29) 
 
 
 
fat/blood
2
log P    0.474  0.016 –  0.005 –  1.577 –  2.246  1.560  
N  126,  R  0.847,  SD  0.304,  F  132.7
in vitro   
   
E S A B V
 (30) 
 
 
 
fat/blood
2
log P    0.077  0.249 –  0.215  –  0.902 –  1.523  1.234 –  1.013  
N  50,  R  0.811,  SD  0.33 F  30.7
in vivo   
   
E S A B V Ic
 (31) 
Liver (Abraham et al., 2007a):  
 
 
 
liver/air
2
logK    0.943  0.836  2.836  2.081  0.561   
 N  124,  R  0.927,  SD  0.256,  F  376.8
in vitro      
   
S A B L
 (32) 
 
 
 
liver/blood
2
log P    0.095 –  0.366 –  0.357 –  0.180  0.730   
N  125,  R  0.583,  SD  0.228,  F  41.9
in vitro   
   
S A B V
 (33) 
 
 
 
liver/blood
2
log P    0.292 –  0.296 –  0.334  0.181  0.337 –  0.597           
  N  85,  R  0.522,  SD  0.420,  F  17.3
in vivo   
   
S A B V Ic
(34) 
Lung (Abraham et al., 2008a): 
 
 
 
lung/air
2
logK    1.250  0.639  1.038  3.661  3.041  0.420                      
   N  44,  R  0.968,  SD  0.250,  F  231.8
in vitro       
   
E S A B L
 (35) 
 
 
 
lung/blood
2
 log P     0.143 –  0.383  0.308                                                         
   N  43,  R  0.264,  SD  0.190,  F  7.2
in vitro   
   
B V
 (36) 
Correlations obtained by regression analysis of experimental drug partition coefficient data 
are denoted as “in vivo”, and correlations pertaining to volatile organic compound 
partitioning are indicated as “in vitro”. Human and rat partition coefficient data were 
combined into data set used in the regression analyses. The independent variable Ic was 
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needed as an indicator descriptor for carboxylic acids (Ic = 1 for carboxylic acids, Ic = 0 for 
noncarboxylic acid solutes) for the in vivo correlations involving drug molecules. The in vivo 
data sets included partition coefficient data for drug molecules such as nalidixic acid and 
valproic acid. No carboxylic acid solutes were contained in the in vitro data sets. The poor R2 
statistics noted in several of the blood-to-tissue correlations are due, at least in part, to the 
small spread in the log P values and the increased experimental uncertainties as noted 
below. Each derived correlation was validated by training set and test set analyses. Based on 
the validation computations the derived correlations are expected to predict the log Ktissue/air 
and log Ptissue/blood values of additional compounds to within about 0.2 to 0.3 log units.  
As an informational note, the experimental data sets for the in vitro Abraham model 
correlations were determined using the equilibrium vial method. The gas-to-tissue partition 
coefficient of the VOC was calculated from the measured vapor phase composition in the 
headspace above the given tissue. The measured in vitro gas-to-tissue partition coefficients 
were converted to the corresponding blood-to-tissue values, Ptissue/blood values, through Eqn. 
16.  The Ptissue/blood include the experimental uncertainty in both the Ktissue/air and Pblood/air 
values. Should the in vitro experimental air-to-blood partitioning data not be available for 
the conversion, one can estimate the needed Pblood/air values from the three correlation 
models  
 
 
 
blood/air
2
logK human   1.18  0.39  0.97  3.80  2.69  0.41                    
    N  155,  R  0.34,  RSME  0.332,  F  474
      
   
E S A B L
 (37) 
 
 
 
blood/air
2
logK rat   0.75  0.56  1.06  3.64  2.41  0.29                                        
   N  127,  R  0.91,  SD  0.29,  RMSE  0.286,  F  242
      
    
E S A B L
 (38) 
 
 
 
blood/air
2
logK human or rat   1.069  0.456  1.083  3.738  2.580  0.376          
  N  196. R  0.938,  SD  0.324,  RMSE  0.319,  F  572.8
      
    
E S A B L
(39) 
reported by Abraham and coworkers (2005). For any fully characterized system/process 
(those with calculated values for the equation coefficients) further values of SP (see Eqns. 1 
and 2) can be estimated for solutes with known values for the solute descriptors. Solute 
descriptors can be obtained by regression analysis of measured drug solubilities in organic 
solvents and measured water-to-solvent and organic solvent-to-organic solvent partition 
coefficients as discussed above. 
8. Abraham solvation parameter model: prediction of water-to-skin and 
blood-to-skin partition coefficients and skin permeability coefficients 
Human skin is an important permeation barrier that controls the entry of chemicals into the 
body. The barrier properties of skin depend primarily on the outer skin cells, which are 
called the stratum corneum. The stratum corneum consists of multiple non-living layers of 
densely packed keratin-filled cells embedded in a lipid-rich extracellular matrix containing a 
mixture of ceramides, fatty acids, cholesterol and triglycerides (Monteiro-Riviere et al., 2001). 
The multiple layers are 7 – 16 micrometers in total thickness in most regions of the human 
body; however, in the palms of the hands and soles of the feet a much total layer thickness 
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of 400 – 600 micrometers is found (Holbrook and Odland, 1974) For a chemical to be 
absorbed into the body after dermal exposure, it must first dissolve in the stratum corneum 
and then diffuse through the remaining epidermis sub-layers and into the dermis layer, 
from where it will eventually enter the blood stream. Passive diffusion is the mechanism by 
which chemicals move through the stratum corneum. Passage through the remaining sub-
layers of the skin is more rapid. 
Penetration of a compound into the skin is controlled by the compound’s chemical structure 
and physicochemical properties. Lipophilicity and hydrogen-bonding character play a major 
role in a compound’s skin absorption profile. In general, substances possessing the greater 
lipophilicity are more readily absorbed by the skin than compounds with lesser 
lipophilicity. Dermal absorption generally increases with increasing water-to-octanol 
partition coefficient from log POtOH/water = -1 to log POtOH/water = 3.5. Highly lipophilic 
compounds (those with log POtOH/water > 5) pass easily through the stratum corneum, but are 
generally too water-insoluble to pass through the remaining epidermis sub-layers to enter 
the blood stream. There has been increasing experimental evidence that ionized species can 
contribute to transdermal absorption (Netzlaff et al., 2006; Abraham and Martins, 2004; 
Michaels et al., 1975). When the penetrating compound can exist in both ionized and 
unionized forms, it is the unionized form that penetrates faster through the lipid regions. 
Some contribution of the ionized form to the overall permeability, however, is expected. The 
solubilizing vehicle and formulation ingredients can alter the skin penetration of a 
compound by affecting the barrier properties of the skin by a range of mechanisms 
including hydration, delipidization, fluidization and desmosome disruption in the stratum 
corneum, or by changing the partitioning of the compound into the stratum corneum. 
Skin partitioning is important in the pharmaceutical industry as many medications are 
applied topically to the skin in ointments, in creams, in lotions and gels, and in skin patches. 
Once applied, the medication often needs to find its way into the blood system for delivery 
to the desired target site. Abraham and Martins (2004) developed a mathematical correlation 
between the water-to-skin partition coefficient, Ksc, and the Abraham solute descriptors 
  sc 2
Log K  0.341  0.341 –  0.206 –  0.024 –  2.178  1.850                                         
    N  45,  SD  0.216,  R  0.926,  F  97
  
   
E S A B V
 (40) 
based on an experimental database containing 45 solutes, including several linear alcohols 
(e.g. methanol through 1-decanol) and several fairly large steroidal molecules (e.g. 
testosterone, progesterone, hydrocortisone, corticosterone, and aldosterone) and steroid 
esters (e.g. hydrocortisone-21 acetate, hydrocortisone-21 pentanoate, cortisone-21 acetate, 
cortisone-21 octanoate). Careful examination of Eqn. 40 reveals that the water-to-skin 
partition coefficient increases with increasing solute size, and decreasing with increasing 
solute polarity and solute hydrogen-bonding character.   
Abraham and Ibrahim (2007) compiled experimental data on the distribution coefficients of 
drugs from blood or plasma to rat skin and rabbit skin. The authors analyzed the 
experimental log Pskin data in accordance with Eqn. 1 of the Abraham model 
  skin 2
log P  0.253 –  0.189 –  0.620  0.713 –  0.683  0.059                                
   N  59,  SD  0.26,  R  0.733,  F  29
   
   
acid rabbitA B V I I
 (41) 
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The e · E and s · S terms were not statistically significant and were eliminated from the final 
derived correlation model. The poor R2 statistics for Eqn. 41 is due, at least in part, to the 
small spread in the values of log Pskin, from log Pskin = -0.82 to log Pskin = 1.61, for a range of 
only 2.43 log units. Carboxylic acids were found to be systematically retained in blood or 
plasma more than calculated. An indicator descriptor, Iacid, was needed to describe the log 
Pskin data of solutes containing a carboxylic acid functional group. The Iacid descriptor 
equals unity for carboxylic acid solutes, and takes the value of Iacid = 0 for all other 
compounds. The second indicator descriptor in Eqn. 41 was needed to combine the rat skin 
(Irabbit = 0) and rabbit skin (Irabbit) partitioning data into a single correlation model. The 0.059 
Irabbit term amounts to a 0.059 log unit offset, which is likely less than the experimental 
uncertainty in the measured log Pskin data. If the 0.059 Irabbit term is omitted, the squared 
correlation coefficient decreases to R2 = 0.608. 
Theoretical models of passive diffusion are based on Fick’s law of diffusion and the 
conversation of particle numbers. Fick’s law of diffusion states that a chemical diffuses from 
a region of higher concentration to a region of lower concentration with a magnitude that is 
directly proportional to the chemical’s concentration gradient. When applied to trans-
stratum corneum diffusion, the amount of chemical passing through a unit area of the 
stratum corneum per unit time (J) is given by 
 
,p scK D C
J
h
  (42) 
where Kp,sc is the chemical’s solvent-to-stratum corneum partition coefficient, D represents 
the chemical’s diffusivity in the stratum corneum lipid matrix and h is the apparent skin 
thickness (i.e., the diffusion pathlength). Under the assumption of constant donor 
concentration and sink conditions (zero receptor phase concentration) Eqn. 42 simplifies to 
 
,p sc donor
SS
K DC
J
h
  (43) 
The permeability coefficient, kp, is the coefficient of proportionality between the steady-state 
flux JSS and the donor concentration, Cdonor. 
Skin permeability experiments are generally performed in vitro using a Franz diffusion cell 
(shown in Figure 8). A freshly excised skin sample is mounted on the receptor compartment 
of the Franz cell with the stratum corneum facing upwards into the donor compartment and 
the dermis facing the receptor compartment. The latter compartment is filled with the 
receptor solution (often a phosphate saline solution buffered at pH of 7.4), and maintained 
at a constant temperature of 37 oC with a water jacketed cell under constant stirring. The 
donor compartment is filled with the vehicle solution containing the dissolved chemical of 
interest. At appropriate time intervals, aliquots of the receptor medium are withdrawn for 
analysis, and immediately replaced with an equal volume of fresh medium. Alternative 
diffusion cell designs and mathematical procedures for calculating the drug’s diffusivity 
and permeability coefficient from the experimental permeation results are described in 
greater detail elsewhere (Friend, 1992; Hathout et al., 2010). For in vitro skin penetration 
studies, the skin retention of a drug can be assessed by the use of radiolabeled drugs 
(usually carbon-14 or tritium labeled). Skin samples should be exposed to the drug for no 
more than a maximum of 24 hours because of deterioration of skin integrity with time. 
www.intechopen.com
 
Toxicity and Drug Testing 
 
122 
 
Fig. 8. Franz diffusion cell used to measure skin permeability coefficients 
The parallel artificial membrane permeability assay (PAMPA) has been suggested as a high 
throughput screening method for rapid determination of passive transport permeability in 
connection with gastrointestinal (GI) absorption (Sugano et al., 2002), blood-brain barrier 
penetration (Mensch et al., 2010 and skin permeation (Ottaviani et al., 2006). In the PAMPA 
method a 96-well filter plate coated with a liquid membrane is used to separate the donor 
and receptor compartments. Artificial membrane selection depends on the transport 
property to be determined. Ottaviani et al. (2006) found a reasonably accurate mathematical 
correlation between human skin permeability coefficient, kp, and the effective permeability 
coefficient, keff, for a set of 31 compounds 
 
p eff
2
log k  1.34 log k  0.28                
 N  31,  SD  0.42,  R  0.81,  F  31
 
       (44) 
tested through an artificial membrane consisting of 70 % silicone and 30 % isopropyl 
myristate. The authors further noted that presence of isopropyl myristate as only a 
hydrogen-bond acceptor group in the artificial membrane was in accord with previous 
results demonstrating that stratum corneum lipids were better hydrogen-bond acceptors 
than hydrogen-bond donors.  
Abraham and Martins (2004) reported an Abraham model correlation for human skin 
permeability coefficients from aqueous solution, kp, 
 
 
 
p
2
Log k cm /s   5.426 –  0.106 –  0.473 –  0.473 –  3.000  2.296                                   
N  119,  SD  0.461,  R  0.832,  F  112
  
   
E E A B V
 (45) 
based on a database containing 119 experimental values at a common temperature of 37 oC. 
The authors adjusted the experimental data for ionization by assuming that the measured 
permeability coefficient was a simple addition of terms in Eqn. 46 
 p neutral p,neutral ionic p,ionick  f  k    f k   (46) 
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where, kp, kp,ionic, and kp,neutral represent the overall permeation coefficient, that due to the 
ionic species, and that due to the neutral species; fionic and fneutral denote the fraction of ionic 
and neutral species at a given pH. For ionizable acids the skin permeability coefficient of the 
neutral molecule, kp,neutral, was so much larger than the skin permeability coefficient of the 
ionic form, kp,ionic, that the experimental unadjusted values of kp was adjusted to give 
kp,neutral from the fraction of the neutral form present under the experimental conditions of 
pH. For ionizable bases the ratio of kp,neutral to kp,ionic was assumed to be 17.5, and this value 
was used to obtain kp,neutral values from experimental unadjusted values of kp. If the 
experimental pH is near to the basic pKa, such an adjustment will be very close to the 
adjustment that assumes negligible permeation of ionizable species. But as the difference in 
(pH − pKa) becomes larger, the adjustment will be smaller than that of negligible permeation 
of ionic species. To account for the temperature differences, the authors adjusted 
experimental log kp values by 0.20 units from 32 °C to 37 °C, and by 0.48 units from 25 °C to 
37 °C. The main factors that influence log kp are hydrogen bond basicity (b · B term) that 
decreases log kp, and solute volume (v · V term) that increases log kp. Solute 
dipolarity/polarizability (s · S term) and hydrogen bond acidity (a · A term) make minor 
contributions, both in the sense of lowering log kp. 
9. Conclusion 
The Abraham solvation parameter model provides an in silico method for estimating 
ADMET properties of potential drug molecules in the early stages of drug discovery. To 
date mathematical expressions have been reported for predicting water-to-organic solvent 
partition coefficients and solubilities in more than 70 organic solvents, air-to-tissue and 
blood-to-tissue partition coefficients for 5 human and rat tissues, water-to-human skin and 
blood-to-rat/rabbit skin partitions, human skin permeability coefficients, and rat (Zhao et 
al., 2003) and human (Zhao et al., 2002) intestinal absorption. Expressions are also available 
for estimating Draize rabbit eye test scores for pure liquids and eye irritation thresholds in 
humans (Abraham et al., 2003), odor detection thresholds and nasal pungency of volatile 
organic compounds (VOCs) (Abraham et al., 2007b), and the minimum alveolar 
concentration (MAC) for inhalation anesthetics in rats (Abraham et al., 2008b). The number 
of derived Abraham model correlations is expected in future years as more experimental 
data becomes available. Predictive applications require as input parameters the numerical 
values of the drug candidate’s solute descriptors, which are easily calculable from measured 
solubility and partition coefficient data. 
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